Prostate cancer screening: a question of common sense

Louis Denis

First results of randomised clinical screening trials are traditionally met with a barrage of comments by opinionated observers, and the back-to-back publication in the March 26 issue of the New England Journal of Medicine on the mortality results of two major PSA screening trials – one European, one American – was no exception. Not only did it reignite the existing controversy but it brought utter confusion to the professional and public media.

Download full article

Be the first to comment

Leave a Reply

Your email address will not be published.